Sep 22, 2026 17 0
Uploaded by Eliana
Favorite
Share
More Options
12
NF1/2 mutations predict favorable benefit from immune checkpoint inhibitor-based therapies over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma_Page 1

Open in WPS to view all 12 pages